These resources are offered to clinicians for use with their patients with hematologic malignancies and their families, when discussing biosimilars as treatment options. They offer a wealth of information about what biosimilars are, how they work, and their safety and efficacy. The resources are available in both English and Spanish.
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Pfizer, Inc.